Inventor
OLEJNICZAK EDWARD T
US17 patents
⚠️ This page may combine multiple inventors who share the name “OLEJNICZAK EDWARD T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VANDERBILT
12 patentsUS10533010B2Jan 14, 2020
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT3 citations71
US10501466B2Dec 10, 2019
WDR5 inhibitors and modulators
UNIV VANDERBILT3 citations71
US10160763B2Dec 25, 2018
WDR5 inhibitors and modulators
UNIV VANDERBILT5 citations71
US10954193B2Mar 23, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations61
US12195472B2Jan 14, 2025
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US11208415B2Dec 28, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US12144816B2Nov 19, 2024
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations59
US11596639B2Mar 7, 2023
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT1 citations59
US10005728B2Jun 26, 2018
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations50
US10844032B2Nov 24, 2020
Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations49
US10093640B2Oct 9, 2018
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
UNIV VANDERBILT0 citations49
US9949965B2Apr 24, 2018
Tricyclic indole Mcl-1 inhibitors and uses thereof
UNIV VANDERBILT0 citations40
ABBOTT LAB
3 patentsUS5891643AApr 6, 1999
Use of nuclear magnetic resonance to design ligands to target biomolecules
ABBOTT LAB67 citations95
US6043024AMar 28, 2000
Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
ABBOTT LAB38 citations92
US5989827ANov 23, 1999
Use of nuclear magnetic resonance to design ligands to target biomolecules
ABBOTT LAB44 citations92